Tecentriq (atezolizumab) - Roche
Fusion-VAC-XS15 - University Hospital Tuebingen
DNAJB1-PRKACA peptide vaccine - BMS
https://dgho2024.abstractserver.com/program/#/details/presentations/730
 
Hackenbruch C.1,2,3; Bauer J.2,3; Heitmann J.S.1,2,3; Maringer Y.2,3; Nelde A.2,3; Denk M.2,4; Zieschang L.2,4; Kammer C.2; Jung S.1,2,3; Missios P.5; Englisch A.1,2,3,6; Arefi M.1,2,3,7; Bonzheim I.8; Salih H.R.1,3; Bitzer M.3,4,5,9; Walz J.S.1,2,3,4
 
Oct 13, 2024
 
Next